157 related articles for article (PubMed ID: 35121210)
21. Trends in anticoagulant prescribing: a review of local policies in English primary care.
Ho KH; van Hove M; Leng G
BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
[TBL] [Abstract][Full Text] [Related]
22. Early Initiation of Direct Oral Anticoagulants After Onset of Stroke and Short- and Long-Term Outcomes of Patients With Nonvalvular Atrial Fibrillation.
Mizoguchi T; Tanaka K; Toyoda K; Yoshimura S; Itabashi R; Takagi M; Todo K; Shiozawa M; Yagita Y; Yoshimoto T; Terasaki T; Yamagami H; Takizawa S; Inoue M; Kamiyama K; Ihara M; Okada Y; Kitazono T; Koga M;
Stroke; 2020 Mar; 51(3):883-891. PubMed ID: 31964290
[TBL] [Abstract][Full Text] [Related]
23. Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review.
van der Horst SFB; van Rein N; van Mens TE; Huisman MV; Klok FA
Thromb Res; 2023 Nov; 231():135-140. PubMed ID: 37005194
[TBL] [Abstract][Full Text] [Related]
24. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
[TBL] [Abstract][Full Text] [Related]
25. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
[TBL] [Abstract][Full Text] [Related]
26. The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation.
Sakamoto Y; Okubo S; Nito C; Suda S; Matsumoto N; Abe A; Aoki J; Shimoyama T; Takayama Y; Suzuki K; Mishina M; Kimura K
Eur J Neurol; 2017 Nov; 24(11):1399-1406. PubMed ID: 28799181
[TBL] [Abstract][Full Text] [Related]
27. The Dose of Direct Oral Anticoagulants and Stroke Severity in Patients with Acute Ischemic Stroke and Nonvalvular Atrial Fibrillation.
Kato Y; Hayashi T; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1490-1496. PubMed ID: 29398536
[TBL] [Abstract][Full Text] [Related]
28. Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry.
Poli D; Antonucci E; Ageno W; Berteotti M; Falanga A; Pengo V; Chiarugi P; Cosmi B; Paparo C; Chistolini A; Insana A; Lione D; Malcangi G; Martini G; Masciocco L; Pedrini S; Bucherini E; Pastori D; Pignatelli P; Toma A; Testa S; Palareti G; Start Af Study Group
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610775
[No Abstract] [Full Text] [Related]
29. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study.
Zapata-Wainberg G; Masjuan J; Quintas S; Ximénez-Carrillo Á; García Pastor A; Martínez Zabaleta M; Cardona P; Freijo Guerrero MM; Llull L; Benavente Fernández L; Castellanos Rodrigo M; Egido J; Serena J; Vivancos J;
Eur J Neurol; 2019 Feb; 26(2):230-237. PubMed ID: 30153363
[TBL] [Abstract][Full Text] [Related]
30. Effect of Renal Function on Dosing of Non-Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation.
Shrestha S; Baser O; Kwong WJ
Ann Pharmacother; 2018 Feb; 52(2):147-153. PubMed ID: 28856898
[TBL] [Abstract][Full Text] [Related]
31. Cerebral Ischemia in Patients on Direct Oral Anticoagulants.
Macha K; Marsch A; Siedler G; Breuer L; Strasser EF; Engelhorn T; Schwab S; Kallmünzer B
Stroke; 2019 Apr; 50(4):873-879. PubMed ID: 30852963
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation.
Carbone A; Santelli F; Bottino R; Attena E; Mazzone C; Parisi V; D'Andrea A; Golino P; Nigro G; Russo V
Eur J Clin Pharmacol; 2022 May; 78(5):879-886. PubMed ID: 35138442
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018.
Díaz-Guzmán J; Freixa-Pamias R; García-Alegría J; Pérez Cabeza AI; Roldán-Rabadán I; Antolin-Fontes B; Rebollo P; Llorac A; Genís-Gironés M; Escobar-Cervantes C
Rev Esp Cardiol (Engl Ed); 2022 Jun; 75(6):496-505. PubMed ID: 34518112
[TBL] [Abstract][Full Text] [Related]
34. Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases.
Huiart L; Ferdynus C; Renoux C; Beaugrand A; Lafarge S; Bruneau L; Suissa S; Maillard O; Ranouil X
BMJ Open; 2018 Mar; 8(3):e018180. PubMed ID: 29602837
[TBL] [Abstract][Full Text] [Related]
35. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
[TBL] [Abstract][Full Text] [Related]
36. Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis.
De Marchis GM; Seiffge DJ; Schaedelin S; Wilson D; Caso V; Acciarresi M; Tsivgoulis G; Koga M; Yoshimura S; Toyoda K; Cappellari M; Bonetti B; Macha K; Kallmünzer B; Cereda CW; Lyrer P; Bonati LH; Paciaroni M; Engelter ST; Werring DJ
J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):119-125. PubMed ID: 34635567
[TBL] [Abstract][Full Text] [Related]
37. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants.
Caro Martínez C; Elvira Ruiz G; Flores Blanco PJ; Cerezo Manchado JJ; Albendín Iglesias H; Lova Navarro A; Arregui Montoya F; García Alberola A; Pascual Figal DA; Bailén Lorenzo JL; Manzano Fernández S
Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):935-943. PubMed ID: 30497945
[TBL] [Abstract][Full Text] [Related]
39. Preceding direct oral anticoagulant administration reduces the severity of stroke in patients with atrial fibrillation - K-PLUS registry.
Nakajima M; Inatomi Y; Ueda A; Ito Y; Kouzaki Y; Takita T; Wada K; Yonehara T; Terasaki T; Hashimoto Y; Ando Y
J Clin Neurosci; 2021 Jul; 89():106-112. PubMed ID: 34119252
[TBL] [Abstract][Full Text] [Related]
40. Reduced Doses of Direct Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
Deguchi I; Takao M
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):354-359. PubMed ID: 30401611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
